The U.S. Organ-on-a-Chip Market is witnessing remarkable growth as pharmaceutical companies, biotechnology firms, research institutes, and regulatory organizations increasingly adopt microphysiological systems to improve drug development and disease modeling. Organ-on-a-chip technology combines microfluidics, tissue engineering, and living human cells to create miniature models that replicate...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek